IMUX Stock Forecast: Price target


IMUX Stock Forecast: The outlook is positive. The stock is a buy.

IMUX Stock Forecast: Price today

IMUX Stock Forecast: Recent Performance

Stock name 5 days 1 month YTD
IMUX +19.5% +150.4% +9.8%
NASDAQ -1.6% -5.8% -15.2%

IMUX Stock Forecast: Latest News

IMUX declares a $60 million securities purchase agreement: IMUX recently announced a $60 million oversubscribed private placement equity financing. The securities purchase agreement took place to issue and sell around 8.69 million shares at $4.35 per share and pre-funded warrants to buy up to 5 million shares at $4.34 per pre-funded warrant share. The expected gross proceeds from the PIPE are $60 million. The company plans to use the funds raised to finance its top three product candidates vidofludimus calcium (IMU-838), IMU-935, IMU-856, and for corporate purposes. This financing led the stock to soar high by almost 20% in the past 5 days and by 150% in the past month.


IMUX Stock Forecast: Latest Video

YouTube video

IMUX Stock Forecast: Price target

IMUX Stock Forecast: Q2 Results

IMUX released its Quarter 2 (which ended on June 2022) in August 2022.

The company’s operating expenses were reported as $20.6 million, which increased by 7.5% from $19.2 million in the same quarter, the previous year.

The company’s operating income decreased by 7.5% over a year and was reported as -$20.6 million.

Earnings from continuing operations were declared as -$21.9 million, down 22.1% YoY.

Research and development expenses were $16.5 million, up 5%.

Its net income was -$21.9 million, down 22.1% YoY.

Diluted earnings per share (EPS) were declared as -$0.72, down 12.2% YoY.

Its EBIT was declared as -$20.6 million, down 7.51% YoY.

IMUX Stock Price Prediction: Short-Term Outlook

Overall Positive
1. Market’s Wisdom Positive
1a. Market Data Neutral
Volume Lower
Performance vs NASDAQ (Last 5 days) Higher
1b. Technical Buy
2. Crowd’s Wisdom Neutral
2aGoogle Search Lower
2b. Social Media Sentiment Higher

IMUX Stock Forecast: Latest Tweet

$IMUX‘s in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for this and other indicators: #Immunic #stockmarket #stock

IMUX Stock Forecast: Conclusion

The recent financing led to a sudden increase in the stock price, which is the highest in the past 6 months. The company after its two major failures in the previous years has shown quite a progress in the phase-2 trial of vidofludimus calcium (IMU-838) for patients with multiple sclerosis which was noteworthy, but there is a lot to do in the Multiple sclerosis market with numerous players. So, this can be considered a good investment but the company has to focus on driving more positive results and should stand out in the market.


Bommu Vaishnavi

Gold Price Forecast: Gold Price Rises above $1,650, Outlook Turns Bullish?

Note: Crowdwisdom360 collates Predictions and data from all over the net and has no in-house view on the likely trends in the Stocks or Crypto Coins. Please consult a registered investment advisor to guide you on your financial decisions.


Source link